The transition from traditional newborn blood spot testing to full genomic sequencing creates a massive volume of individual-level data vulnerable to law enforcement surveillance. As clinical practices in 2026 increasingly favor comprehensive genomic profiles over limited metabolic screens, the
The 7th Circuit Court of Appeals has upheld Arkansas's Pharmacy Benefit Manager reporting rules, requiring health plans to disclose pharmacy compensation data despite ERISA preemption challenges. This landmark decision marks a significant turning point in the 2026 regulatory environment, signaling
Senior managers and board members face personal legal liability for algorithmic outcomes under the Senior Managers and Certification Regime regardless of technical complexity. The rapid integration of artificial intelligence across the insurance distribution value chain has initiated a profound
The transition to agentic AI provides a durable path toward a more transparent healthcare ecosystem by automating the chasing of data and filling of documentation gaps. Despite the billions of dollars allocated to digital transformation over the past several years, health insurance remains a domain
Separating raw, curated, and trusted data zones within a lakehouse model ensures teams can explore insights without compromising regulatory compliance. As the insurance industry faces heightened volatility in 2026, the reliance on fragmented legacy systems has become a significant liability for
A sudden shift in AM Best’s assessment from appropriate to marginal enterprise risk management highlights the severe impact of recent internal control failures at SanlamAllianz Re. On October 5, 2026, the global credit rating agency announced a significant downgrade for the Mauritius-based
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29